Counterfeit Ozempic: A Growing Threat to Pharmaceutical Integrity
In 2023, counterfeit Ozempic products emerged in Europe and the US, posing significant risks to patient safety. The rise of fake pharmaceuticals highlights the urgent need for robust traceability and supply chain security, especially for high-demand drugs like Ozempic. Advanced solutions such as Domino Printing’s systems provide essential safeguards to help manufacturers track and authenticate products throughout the supply chain, ensuring patient safety and compliance.
At Codico Distributors, we enable businesses to boost their traceability capabilities through innovative coding, marking, labelling, and automation systems. These systems provide numerous benefits, including enhanced product identification, improved regulatory compliance, and protection against counterfeiting. Our coding and marking solutions apply precise, durable codes to product packaging, ensuring that vital data such as batch numbers, etc are always visible and easily traceable. This is critical in detecting counterfeit goods and ensuring the authenticity of medications.
Domino’s solutions work seamlessly within your existing manufacturing processes, providing high-speed and accurate labelling and coding that integrates with automation systems. By reducing manual intervention, manufacturers can improve efficiency while ensuring the traceability and security of every product. Tamper-evident labelling further enhances product integrity, providing visual cues to detect any unauthorised access or alterations.
In today’s complex global supply chains, securing the authenticity of pharmaceutical products is vital. With Codico’s technologies, pharmaceutical and life sciences manufacturers can ensure their products remain secure from production to the end consumer. Our solutions help protect patients, preserve brand integrity, and meet the increasingly stringent regulatory demands of the industry.
